Great Lakes Advisors LLC Invests $9.76 Million in Danaher Corporation $DHR

Great Lakes Advisors LLC bought a new position in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, HoldingsChannel.com reports. The institutional investor bought 13,556 shares of the conglomerate’s stock, valued at approximately $9,761,000.

Other hedge funds have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares during the last quarter. Legal & General Group Plc grew its position in Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after acquiring an additional 43,169 shares during the last quarter. Advisors Capital Management LLC increased its stake in Danaher by 14.0% in the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after purchasing an additional 6,720 shares during the period. Handelsbanken Fonder AB lifted its position in Danaher by 10.9% in the second quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after purchasing an additional 28,425 shares during the last quarter. Finally, Swiss Life Asset Management Ltd lifted its position in Danaher by 12.1% in the fourth quarter. Swiss Life Asset Management Ltd now owns 115,335 shares of the conglomerate’s stock valued at $26,402,000 after purchasing an additional 12,416 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 6.2%

Shares of NYSE DHR opened at $211.92 on Thursday. The firm has a fifty day simple moving average of $194.30 and a two-hundred day simple moving average of $192.44. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $148.98 billion, a PE ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the previous year, the firm posted $0.77 EPS. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Analysts Set New Price Targets

DHR has been the topic of several recent analyst reports. Argus cut their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Stifel Nicolaus dropped their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Guggenheim cut their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, TD Cowen lowered their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $228.91.

Get Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.